BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10676646)

  • 1. Imaging brain tumor proliferative activity with [124I]iododeoxyuridine.
    Blasberg RG; Roelcke U; Weinreich R; Beattie B; von Ammon K; Yonekawa Y; Landolt H; Guenther I; Crompton NE; Vontobel P; Missimer J; Maguire RP; Koziorowski J; Knust EJ; Finn RD; Leenders KL
    Cancer Res; 2000 Feb; 60(3):624-35. PubMed ID: 10676646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of brain tumor proliferative activity with iodine-131-iododeoxyuridine.
    Tjuvajev JG; Macapinlac HA; Daghighian F; Scott AM; Ginos JZ; Finn RD; Kothari P; Desai R; Zhang J; Beattie B
    J Nucl Med; 1994 Sep; 35(9):1407-17. PubMed ID: 8071684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET imaging drug distribution after intratumoral injection: the case for (124)I-iododeoxyuridine in malignant gliomas.
    Roelcke U; Hausmann O; Merlo A; Missimer J; Maguire RP; Freitag P; Radü EW; Weinreich R; Gratzl O; Leenders KL
    J Nucl Med; 2002 Nov; 43(11):1444-51. PubMed ID: 12411546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iododeoxyuridine uptake and retention as a measure of tumor growth.
    Tjuvajev J; Muraki A; Ginos J; Berk J; Koutcher J; Ballon D; Beattie B; Finn R; Dahighian F; Blasberg R
    J Nucl Med; 1993 Jul; 34(7):1152-62. PubMed ID: 8315494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative kinetics of [124I]FIAU in cat and man.
    Jacobs A; Bräunlich I; Graf R; Lercher M; Sakaki T; Voges J; Hesselmann V; Brandau W; Wienhard K; Heiss WD
    J Nucl Med; 2001 Mar; 42(3):467-75. PubMed ID: 11337525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter.
    Spence AM; Muzi M; Mankoff DA; O'Sullivan SF; Link JM; Lewellen TK; Lewellen B; Pham P; Minoshima S; Swanson K; Krohn KA
    J Nucl Med; 2004 Oct; 45(10):1653-9. PubMed ID: 15471829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F alpha-methyl tyrosine PET studies in patients with brain tumors.
    Inoue T; Shibasaki T; Oriuchi N; Aoyagi K; Tomiyoshi K; Amano S; Mikuni M; Ida I; Aoki J; Endo K
    J Nucl Med; 1999 Mar; 40(3):399-405. PubMed ID: 10086702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot clinical trial of 5-[125I]iodo-2'-deoxyuridine in the treatment of colorectal cancer metastatic to the liver.
    Macapinlac HA; Kemeny N; Daghighian F; Finn R; Zhang J; Humm J; Squire O; Larson SM
    J Nucl Med; 1996 Apr; 37(4 Suppl):25S-29S. PubMed ID: 8676200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorodeoxyuridine improves imaging of human glioblastoma xenografts with radiolabeled iododeoxyuridine.
    Dupertuis YM; Vazquez M; Mach JP; De Tribolet N; Pichard C; Slosman DO; Buchegger F
    Cancer Res; 2001 Nov; 61(21):7971-7. PubMed ID: 11691821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiolabeled nucleoside analogs in cancer diagnosis and therapy.
    Kassis AI; Adelstein SJ; Mariani G
    Q J Nucl Med; 1996 Sep; 40(3):301-19. PubMed ID: 8961807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simplified quantification of FDG metabolism in tumors using the autoradiographic method is less dependent on the acquisition time than SUV.
    Burger IA; Burger C; Berthold T; Buck A
    Nucl Med Biol; 2011 Aug; 38(6):835-41. PubMed ID: 21843779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
    Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proliferation kinetics of human brain tumors by in situ double labeling with bromodeoxyuridine and iododeoxyuridine].
    Maeda T; Hoshino T
    No To Shinkei; 1992 Sep; 44(9):821-5. PubMed ID: 1476811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor localization and systemic absorption of intravesical instillation of radio-iodinated iododeoxyuridine in patients with bladder cancer.
    Chiou RK; Dalrymple GV; Baranowska-Kortylewicz J; Holdeman KP; Schneiderman MH; Harrison KA; Taylor RJ
    J Urol; 1999 Jul; 162(1):58-62. PubMed ID: 10379740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-[123I/125I]iodo-2'-deoxyuridine in metastatic lung cancer: radiopharmaceutical formulation affects targeting.
    Semnani ES; Wang K; Adelstein SJ; Kassis AI
    J Nucl Med; 2005 May; 46(5):800-6. PubMed ID: 15872354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor targeting by intra-arterial infusion of 5-[123I]iodo-2'-deoxyuridine in patients with liver metastases from colorectal cancer.
    Mariani G; Di Sacco S; Volterrani D; Di Luca L; Buralli S; Di Stefano R; Baranowska-Kortylewicz J; Bonora D; Matteucci F; Ricci S; Bellina CR; Falcone A; Salvadori PA; Mosca F; Adelstein SJ; Kassis AI
    J Nucl Med; 1996 Apr; 37(4 Suppl):22S-25S. PubMed ID: 8676199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral administration of 5-[123I]iodo-2'-deoxyuridine in a patient with a brain tumor.
    Kassis AI; Tumeh SS; Wen PY; Baranowska-Kortylewicz J; Van den Abbeele AD; Zimmerman RE; Carvalho PA; Garada BM; DeSisto WC; Bailey NO; Castronovo FP; Mariani G; Black PM; Adelstein SJ
    J Nucl Med; 1996 Apr; 37(4 Suppl):19S-22S. PubMed ID: 8676198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between apparent diffusion coefficients on diffusion-weighted MRI and standardized uptake value on FDG-PET/CT in pancreatic adenocarcinoma.
    Sakane M; Tatsumi M; Kim T; Hori M; Onishi H; Nakamoto A; Eguchi H; Nagano H; Wakasa K; Hatazawa J; Tomiyama N
    Acta Radiol; 2015 Sep; 56(9):1034-41. PubMed ID: 25267921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiolabelled 5'-iodo-2'-deoxyuridine: a promising alternative to [18F]-2-fluoro-2-deoxy-D-glucose for PET studies of early response to anticancer treatment.
    Carnochan P; Brooks R
    Nucl Med Biol; 1999 Aug; 26(6):667-72. PubMed ID: 10587105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging glioma extent with 131I-TM-601.
    Hockaday DC; Shen S; Fiveash J; Raubitschek A; Colcher D; Liu A; Alvarez V; Mamelak AN
    J Nucl Med; 2005 Apr; 46(4):580-6. PubMed ID: 15809479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.